• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-200 家族、miR-205 的表达及上皮-间质转化标志物预测食管胃交界腺癌内镜黏膜下剥离术优于食管切除术:单中心经验。

Expression of the microRNA-200 Family, microRNA-205, and Markers of Epithelial-Mesenchymal Transition as Predictors for Endoscopic Submucosal Dissection over Esophagectomy in Esophageal Adenocarcinoma: A Single-Center Experience.

机构信息

Institute of Pathology, Paracelsus Medical University/Salzburger Landeskliniken (SALK), 5020 Salzburg, Austria.

Cancer Cluster Salzburg, 5020 Salzburg, Austria.

出版信息

Cells. 2020 Feb 20;9(2):486. doi: 10.3390/cells9020486.

DOI:10.3390/cells9020486
PMID:32093260
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7072807/
Abstract

Endoscopic submucosal dissection (ESD) is an effective treatment of early esophageal adenocarcinomas (EACs). The decision of ESD over esophagectomy is based on clinical evaluation of tumor depth and invasion. On a molecular level, tumor invasion is strongly associated with epithelial-to-mesenchymal transition (EMT). Here, we investigated whether localized ESD-resected and surgically resected EAC samples displayed different expression profiles of EMT protein and microRNA markers and whether these different expression profiles were able to retrospectively discriminate localized and surgically resected samples. By doing this, we aimed to evaluate whether preoperative measurement of EMT marker expression might support the decision regarding ESD over surgery. The results showed that ESD-resected samples displayed an epithelial expression profile, i.e., high expression of epithelial protein markers, whereas surgically resected samples displayed high expression of mesenchymal markers. In addition, the anti-EMT microRNA-205 was significantly more expressed in ESD-resected samples, whereas we found no significant differences in the expression levels of microRNA-200 family members. Furthermore, in our retrospective approach, we have demonstrated that measurement of selected EMT markers and microRNA-205 has significant discrimination power to distinguish ESD-resected and surgically resected samples. We suggest that the assessment of EMT status of EAC samples on a molecular level may support clinical evaluation regarding the applicability of ESD.

摘要

内镜黏膜下剥离术(ESD)是治疗早期食管腺癌(EAC)的有效方法。ESD 优于食管切除术的决策基于肿瘤深度和侵袭的临床评估。在分子水平上,肿瘤侵袭与上皮间质转化(EMT)密切相关。在这里,我们研究了局部 ESD 切除和手术切除的 EAC 样本是否显示 EMT 蛋白和 microRNA 标志物的不同表达谱,以及这些不同的表达谱是否能够回溯性地区分局部和手术切除的样本。通过这样做,我们旨在评估 EMT 标志物表达的术前测量是否可能支持 ESD 优于手术的决策。结果表明,ESD 切除样本显示出上皮表达谱,即上皮蛋白标志物的高表达,而手术切除样本则显示出高表达的间充质标志物。此外,抗 EMT microRNA-205 在 ESD 切除样本中表达显著增加,而 microRNA-200 家族成员的表达水平没有显著差异。此外,在我们的回顾性方法中,我们已经证明,测量选定的 EMT 标志物和 microRNA-205 具有显著的区分能力,可以区分 ESD 切除和手术切除的样本。我们建议,对 EAC 样本的 EMT 状态进行分子水平评估可能有助于临床评估 ESD 的适用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbef/7072807/7b2556fca2f0/cells-09-00486-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbef/7072807/ba9a3678967a/cells-09-00486-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbef/7072807/d5348011bcbd/cells-09-00486-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbef/7072807/fa7587765485/cells-09-00486-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbef/7072807/739a949d434d/cells-09-00486-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbef/7072807/24529fb81e1d/cells-09-00486-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbef/7072807/0c3341429370/cells-09-00486-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbef/7072807/7b2556fca2f0/cells-09-00486-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbef/7072807/ba9a3678967a/cells-09-00486-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbef/7072807/d5348011bcbd/cells-09-00486-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbef/7072807/fa7587765485/cells-09-00486-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbef/7072807/739a949d434d/cells-09-00486-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbef/7072807/24529fb81e1d/cells-09-00486-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbef/7072807/0c3341429370/cells-09-00486-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbef/7072807/7b2556fca2f0/cells-09-00486-g007.jpg

相似文献

1
Expression of the microRNA-200 Family, microRNA-205, and Markers of Epithelial-Mesenchymal Transition as Predictors for Endoscopic Submucosal Dissection over Esophagectomy in Esophageal Adenocarcinoma: A Single-Center Experience.miR-200 家族、miR-205 的表达及上皮-间质转化标志物预测食管胃交界腺癌内镜黏膜下剥离术优于食管切除术:单中心经验。
Cells. 2020 Feb 20;9(2):486. doi: 10.3390/cells9020486.
2
Clinicopathologic correlations of superficial esophageal adenocarcinoma in endoscopic submucosal dissection specimens.内镜黏膜下剥离术标本中表浅型食管腺癌的临床病理相关性。
Diagn Pathol. 2021 Nov 27;16(1):111. doi: 10.1186/s13000-021-01169-1.
3
A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett's neoplasia.早期巴雷特肿瘤内镜下黏膜下剥离术与内镜下黏膜切除术的随机试验
Gut. 2017 May;66(5):783-793. doi: 10.1136/gutjnl-2015-310126. Epub 2016 Jan 22.
4
Endoscopic submucosal dissection is associated with less pathologic uncertainty than endoscopic mucosal resection in diagnosing and staging Barrett's-related neoplasia.内镜黏膜下剥离术在诊断和分期 Barrett 相关肿瘤方面比内镜黏膜切除术具有更小的病理不确定性。
Dig Endosc. 2020 Mar;32(3):346-354. doi: 10.1111/den.13487. Epub 2019 Aug 20.
5
Outcomes of Endoscopic Submucosal Dissection vs Esophagectomy for T1 Esophageal Squamous Cell Carcinoma in a Real-World Cohort.内镜黏膜下剥离术与食管切除术治疗 T1 期食管鳞癌的真实世界队列研究结果。
Clin Gastroenterol Hepatol. 2019 Jan;17(1):73-81.e3. doi: 10.1016/j.cgh.2018.04.038. Epub 2018 Apr 25.
6
Long-term outcomes of superficial neoplasia at the esophagogastric junction treated via endoscopic submucosal dissection and endoscopic submucosal tunnel dissection: a cohort study of a single center from China.中国单中心队列研究:经内镜黏膜下剥离术和内镜黏膜下隧道剥离术治疗的食管胃交界部表浅肿瘤的长期结局。
Surg Endosc. 2020 Jan;34(1):216-225. doi: 10.1007/s00464-019-06753-7. Epub 2019 Apr 16.
7
Early esophageal cancer in Europe: endoscopic treatment by endoscopic submucosal dissection.欧洲早期食管癌:内镜黏膜下剥离术的内镜治疗。
Endoscopy. 2015 Feb;47(2):113-21. doi: 10.1055/s-0034-1391086. Epub 2014 Dec 5.
8
Endoscopic Submucosal Dissection for Esophageal Adenocarcinoma: A North American Perspective.内镜黏膜下剥离术治疗食管腺癌:北美的视角。
J Gastrointest Surg. 2019 Jun;23(6):1087-1094. doi: 10.1007/s11605-018-04093-w. Epub 2019 Jan 31.
9
Esophagectomy versus observation following endoscopic submucosal dissection of pT1b esophageal adenocarcinoma.内镜黏膜下剥离术治疗 T1b 期食管腺癌后行食管切除术与观察的比较。
Surg Endosc. 2024 Mar;38(3):1342-1350. doi: 10.1007/s00464-023-10623-8. Epub 2023 Dec 19.
10
Endoscopic submucosal dissection for Barrett's early neoplasia: a multicenter study in the United States.经内镜黏膜下剥离术治疗 Barrett 食管早期肿瘤:美国多中心研究。
Gastrointest Endosc. 2017 Oct;86(4):600-607. doi: 10.1016/j.gie.2016.09.023. Epub 2016 Sep 28.

引用本文的文献

1
Molecular Abnormalities and Carcinogenesis in Barrett's Esophagus: Implications for Cancer Treatment and Prevention.巴雷特食管的分子异常与致癌作用:对癌症治疗和预防的启示。
Genes (Basel). 2025 Feb 25;16(3):270. doi: 10.3390/genes16030270.
2
Molecular Biology and Clinical Management of Esophageal Adenocarcinoma.食管腺癌的分子生物学与临床管理
Cancers (Basel). 2023 Nov 14;15(22):5410. doi: 10.3390/cancers15225410.
3
Status of diagnosis and treatment of esophageal cancer and non-coding RNA correlation research: a narrative review.

本文引用的文献

1
Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.整合数据挖掘和荟萃分析探讨 microRNA-200 家族在各种人类恶性肿瘤中的预后作用:对异质性的考虑。
Gene. 2019 Oct 20;716:144025. doi: 10.1016/j.gene.2019.144025. Epub 2019 Aug 5.
2
Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma.基质衍生的白细胞介素 6 驱动食管腺癌的上皮间质转化和治疗抵抗。
Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2237-2242. doi: 10.1073/pnas.1820459116. Epub 2019 Jan 22.
3
食管癌的诊断与治疗现状及非编码RNA相关性研究:一篇叙述性综述
Transl Cancer Res. 2021 Oct;10(10):4532-4552. doi: 10.21037/tcr-21-687.
microRNA involvement in the onset and progression of Barrett's esophagus: a systematic review.
微小RNA参与巴雷特食管的发生和进展:一项系统综述
Oncotarget. 2018 Jan 11;9(8):8179-8196. doi: 10.18632/oncotarget.24145. eCollection 2018 Jan 30.
4
Oesophageal cancer.食管癌。
Lancet. 2017 Nov 25;390(10110):2383-2396. doi: 10.1016/S0140-6736(17)31462-9. Epub 2017 Jun 22.
5
Endoscopic submucosal dissection and endoscopic mucosal resection for early stage esophageal cancer.早期食管癌的内镜黏膜下剥离术和内镜黏膜切除术
Ann Cardiothorac Surg. 2017 Mar;6(2):88-98. doi: 10.21037/acs.2017.03.15.
6
Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients.微小RNA200家族和微小RNA205在胆管癌患者上皮-间质转化及临床结局中的相关性
Int J Mol Sci. 2016 Dec 7;17(12):2053. doi: 10.3390/ijms17122053.
7
Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.食管癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2016 Sep;27(suppl 5):v50-v57. doi: 10.1093/annonc/mdw329.
8
CYR61 and TAZ Upregulation and Focal Epithelial to Mesenchymal Transition May Be Early Predictors of Barrett's Esophagus Malignant Progression.CYR61和TAZ上调以及局灶性上皮-间质转化可能是巴雷特食管恶性进展的早期预测指标。
PLoS One. 2016 Sep 1;11(9):e0161967. doi: 10.1371/journal.pone.0161967. eCollection 2016.
9
BMP4 Signaling Is Able to Induce an Epithelial-Mesenchymal Transition-Like Phenotype in Barrett's Esophagus and Esophageal Adenocarcinoma through Induction of SNAIL2.骨形态发生蛋白4信号通路能够通过诱导SNAIL2,在巴雷特食管和食管腺癌中诱导出类似上皮-间质转化的表型。
PLoS One. 2016 May 18;11(5):e0155754. doi: 10.1371/journal.pone.0155754. eCollection 2016.
10
MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus.微小RNA-205在食管腺癌中起肿瘤抑制作用,而在食管鳞状细胞癌中起癌基因作用。
Tumour Biol. 2016 Jun;37(6):8007-18. doi: 10.1007/s13277-015-4656-8. Epub 2015 Dec 28.